R&D, Pharmacovigilance & Regulatory Affairs_uk

R&D, Pharmacovilance & Regulatory Affairs

Researching, developing, testing and launching new drug solutions. The development process lasts from 8 to 10 years and is made up of 4 phases.

  • R&D, Pharmacovilance & Regulatory Affairs

    Researching, developing, testing and launching new drug solutions. The development process lasts from 8 to 10 years and is made up of 4 phases.

Title Location Date Req ID Sort descending
Reset
Medical Information & PV Officer
Medical Information & PV Officer Zaventem, BE 25 Mar 2026 7089
Zaventem, BE 25 Mar 2026 7089
Clinical Research Physician, Rare Disease
Clinical Research Physician, Rare Disease Europe - remote, IT 23 Mar 2026 7087
Europe - remote, IT 23 Mar 2026 7087
Clinical Program Leader
Clinical Program Leader Cary, NC, US 11 Apr 2026 7017
Cary, NC, US 11 Apr 2026 7017
Clinical Program Leader, Neonatology & Care
Clinical Program Leader, Neonatology & Care Europe, IT 20 Mar 2026 6955
Europe, IT 20 Mar 2026 6955
Master's thesis in computational modelling of aerosol deposition in respiratory system Parma, IT 11 Apr 2026 6598
Senior Manager, CMC Regulatory Affairs, Global Rare Diseases Europe, IT 9 Apr 2026 6592
Senior Director, Clinical Biometrics & Analytics Parma, IT 11 Apr 2026 6387
Senior Director, Clinical Excellence AIR - Bronchiectasis & Non-obstructive Lung Diseases Europe, IT 17 Mar 2026 6111
INTERN - Patient Engagement
INTERN - Patient Engagement PARMA, IT 28 Mar 2026 5993
PARMA, IT 28 Mar 2026 5993
Pharmazeut (all genders) im Praktikum für 2026 / 2027 Hamburg, DE 5 Apr 2026 351